Table:
begin	end	state
1	27	non-cytoplasmic
28	49	transmembrane
50	57	cytoplasmic
58	78	transmembrane
79	89	non-cytoplasmic
90	111	transmembrane
112	127	cytoplasmic
128	150	transmembrane
151	156	non-cytoplasmic
157	176	transmembrane
177	187	cytoplasmic
188	206	transmembrane
207	218	non-cytoplasmic
219	238	transmembrane
239	255	cytoplasmic
256	282	transmembrane
283	301	non-cytoplasmic
302	325	transmembrane
326	350	cytoplasmic
351	373	transmembrane
374	378	non-cytoplasmic
379	398	transmembrane
399	409	cytoplasmic
410	430	transmembrane
431	435	non-cytoplasmic
436	454	transmembrane
455	463	cytoplasmic

Input:
>H281DRAFT_02180
MSLFRKKSVEHMIATSAQNAGLKKALGALDLTFLGVGAIIGTGIFVLTGTGAVQAGPALM
VSFLIAAVACGFAALAYAEFASTIPVAGSIYTYSYATLGELAAWIIGWDLMLEYGLATSA
VSVGWSGYLQSLLSGFGVSLPVALTAAPGALPGHETLFNLPAFLVMMAITALLSVGVRES
ARINNIMVAIKVVVVLLVIAVGVFHVTPANWHPFMPNGWNGVFGAAAVMFFAFIGFDSVS
SAAEEVKNPKRDLPIGIIASLGVCAVLYVAVAAVVTGIVPSAQFANISHPVSYALQVAGQ
KWVAGFIDLGAVLGMLTVILVMAYGQTRVIFAMSRDGLLPARLSRVHPRFATPFFTTWLV
GIFFGLIGALVPLNVLAELINIGTLAAFSMVSIAVLVLRKTHPELPRAFRCPGVPVVPVL
AVASCVFLMANLQAVTWVAFVVWLLIGMVIYFGYSRRRSHLAR

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server